Edesa Biotech, Inc.EDSANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.95
↑ 73% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-7.12
Historical baseline
PeriodValueYoY Change
2025-1.95+15.4%
2024-2.31-53.2%
2023-1.51-95.7%
2022-0.77+88.5%
2021-6.68+38.8%
2020-10.91-4.0%
2019-10.50-89.4%
2018-5.54-264.8%
2017-1.52+94.9%
2016-29.50-